Correlation Between Hepion Pharmaceuticals and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Atea Pharmaceuticals, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Atea Pharmaceuticals.
Diversification Opportunities for Hepion Pharmaceuticals and Atea Pharmaceuticals
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Hepion and Atea is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Hepion Pharmaceuticals and Atea Pharmaceuticals
Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to under-perform the Atea Pharmaceuticals. In addition to that, Hepion Pharmaceuticals is 6.68 times more volatile than Atea Pharmaceuticals. It trades about -0.27 of its total potential returns per unit of risk. Atea Pharmaceuticals is currently generating about -0.06 per unit of volatility. If you would invest 333.00 in Atea Pharmaceuticals on December 28, 2024 and sell it today you would lose (31.00) from holding Atea Pharmaceuticals or give up 9.31% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Hepion Pharmaceuticals vs. Atea Pharmaceuticals
Performance |
Timeline |
Hepion Pharmaceuticals |
Atea Pharmaceuticals |
Hepion Pharmaceuticals and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hepion Pharmaceuticals and Atea Pharmaceuticals
The main advantage of trading using opposite Hepion Pharmaceuticals and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |